Relationship between antigenicity and pathogenicity for Burkholderia pseudomallei and Burkholderia mallei revealed by a large panel of mouse mabs

Hybridoma

Volumn 27, Issue 4, 2008, Pages 231-240

  Zou, Nianxiang ^a   Tsai, Shien ^a   Feng, Shaw Huey ^a   Newsome, Tamara ^a   Kim, Hyung Yong ^a   Li, Bingjie ^a   Zhang, Shimin ^a   Lo, Shyh Ching ^a  

^a ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; GLYCOPROTEIN; LIPOPOLYSACCHARIDE; MONOCLONAL ANTIBODY;

ANTIGENICITY; ARTICLE; BACTERIAL CELL; BACTERIAL STRAIN; BACTERIUM ISOLATE; BURKHOLDERIA MALLEI; BURKHOLDERIA PSEUDOMALLEI; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; ANTIGENS, BACTERIAL; BACTERIAL TYPING TECHNIQUES; BURKHOLDERIA MALLEI; BURKHOLDERIA PSEUDOMALLEI; HYBRIDOMAS; MICE; MICE, INBRED BALB C; VIRULENCE FACTORS;

BACTERIA (MICROORGANISMS); BURKHOLDERIA; BURKHOLDERIA MALLEI; BURKHOLDERIA PSEUDOMALLEI; MUS; NEGIBACTERIA;

EID: 50249164797     PISSN: 15540014     EISSN: None     Source Type: Journal    
DOI: 10.1089/hyb.2008.0012     Document Type: Article

References (18)

1. Chaowagul W, White NJ, Dance DA, Wattanagoon Y, Naigowit P, Davis TM, Looareesuwan S, and Pitakwatchara N: Melioidosis: a major cause of community-acquired septicemia in northeastern Thailand. J Infect Dis 1989;159:890-899.
2. Howe C, Sampath A, and Spotnitz M: The pseudomallei group: a review. J Infect Dis 1971;11:413-425.
3. Leelarasamee A, and Bovornkitti S: Melioidosis: review and update. Rev Infect Dis 1989;11:413-425.
4. Howe C: Glanders. In: The Oxford Medicine. Christian HA (Ed.). Oxford University Press, New York, 1950, pp. 185-202.
5. Howe C, and Miller WR: Human glanders: report of six cases. Ann Intern Med 1947;26:93-115.
6. Ip M, Osterberg LG, Chau PY, and Raffin TA: Pulmonary melioidosis. Chest 1995;108:1420-1424.
7. Jones SM, Ellis JF, Russell P, Griffin KF, and Oyston PC: Passive protection against Burkholderia pseudomallei infection in mice by monoclonal antibodies against capsular polysaccharide, lipopolysaccharide or proteins. J Med Microbiol 2002; 51:1055-1062.
8. Ho M, Schollaardt T, Smith MD, Perry MB, Brett PJ, Chaowagul W, and Bryan LE: Specificity and functional activity of anti-Burkholderia pseudomallei polysaccharide antibodies. Infect Immun 1997;65:3648-3653.
9. Pongsunk S, Thirawattanasuk N, Piyasangthong N, and Ekpo P: Rapid identification of Burkholderia pseudomallei in blood cultures by a monoclonal antibody assay. J Clin Microbiol 1999;37:3662-3667.
10. Steinmetz I, Reganzerowski A, Brenneke B, Haussler S, Simpson A, and White NJ: Rapid identification of Burkholderia pseudomallei by latex agglutination based on an exopolysaccharide-specific monoclonal antibody. J Clin Microbiol 1999;37:225-228.
11. Feng SH, Tsai S, Rodriguez J, Newsome T, Emanuel P, and Lo SC: Development of mouse hybridomas for production of monoclonal antibodies specific to Burkholderia mallei and Burkholderia pseudomallei. Hybridoma 2006;25:193-201.
12. Yokoyama WM: Antibody detection and preparation. In: Current Protocols in Immunology. Coligan JE, Kurisbeek AM, Margulies DH, Shevach EM, and Strober W (Eds.). John Wiley & Sons, New York, 1991.
13. Benz I, and Schmidt MA: Never say never again: protein glycosylation in pathogenic bacteria. Mol Microbiol 2002;45:267-276.
14. Raetz CR, and Whitfield C: Lipopolysaccharide endotoxins. Annu Rev Biochem 2002;71:635-700.
15. Holden MT, Titball RW, Peacock SJ, Cerdeño-Tárraga AM, Atkins T, Crossman LC, Pitt T, Churcher C, Mungall K, Bentley SD, Sebaihia M, Thomson NR, Bason N, Beacham IR, Brooks K, Brown KA, Brown NF, Challis GL, Cherevach I, Chillingworth T, Cronin A, Crossett B, Davis P, DeShazer D, Feltwell T, Fraser A, Hance Z, Hauser H, Holroyd S, Jagels K, Keith KE, Maddison M, Moule S, Price C, Quail MA, Rabbinowitsch E, Rutherford K, Sanders M, Simmonds M, Songsivilai S, Stevens K, Tumapa S, Vesaratchavest M, Whitehead S, Yeats C, Barrell BG, Oyston PC, and Parkhill J: Genomic plasticity of the causative agent of melioidosis, Burkholderia pseudomallei. Proc Natl Acad Sci USA 2004;101:14240-14245.
16. Nierman WC, DeShazer D, Kim HS, Tettelin H, Nelson KE, Feldblyum T, Ulrich RL, Ronning CM, Brinkac LM, Daugherty SC, Davidsen TD, Deboy RT, Dimitrov G, Dodson RJ, Durkin AS, Gwinn ML, Haft DH, Khouri H, Kolonay JF, Madupu R, Mohammoud Y, Nelson WC, Radune D, Romero CM, Sarria S, Selengut J, Shamblin C, Sullivan SA, White O, Yu Y, Zafar N, Zhou L, and Fraser CM: Structural flexibility in the Burkholderia mallei genome. Proc Natl Acad Sci USA 2004;101:14246-14251.
17. Reckseidler SL, DeShazer D, Sokol PA, and Woods DE: Detection of bacterial virulence genes by subtractive hybridization: identification of capsular polysaccharide of Burkholderia pseudomallei as a major virulence determinant. Infect Immun 2001;69:34-44.
18. DeShazer D, Waag DM, Fritz DL, and Woods DE: Identification of a Burkholderia mallei polysaccharide gene cluster by subtractive hybridization and demonstration that the encoded capsule is an essential virulence determinant. Microb Pathog 2001;30:253-269.